Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-ZNF281 antibody (STJ191646) | Login | Anti-ZNF281 antibody (STJ191646) | ||||||||||||||||
|
||||||||||||||||||
Anti-CNNM3 antibody (STJ191904) | Login | Anti-CNNM3 antibody (STJ191904) | ||||||||||||||||
|
||||||||||||||||||
Anti-KIF23 antibody (STJ191905) | Login | Anti-KIF23 antibody (STJ191905) | ||||||||||||||||
|
||||||||||||||||||
Anti-STRN3 antibody (146-196 aa) (STJ191908) | Login | Anti-STRN3 antibody (146-196 aa) (STJ191908) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDH12 antibody (500-580 aa) (STJ191661) | Login | Anti-CDH12 antibody (500-580 aa) (STJ191661) | ||||||||||||||||
|
||||||||||||||||||
Anti-BCL7B antibody (STJ191917) | Login | Anti-BCL7B antibody (STJ191917) | ||||||||||||||||
|
||||||||||||||||||
Anti-CC2D1A antibody (STJ191919) | Login | Anti-CC2D1A antibody (STJ191919) | ||||||||||||||||
|
||||||||||||||||||
Anti-CCNK antibody (80-160 aa) (STJ191667) | Login | Anti-CCNK antibody (80-160 aa) (STJ191667) | ||||||||||||||||
|
||||||||||||||||||
Anti-CCNL2 antibody (400-480 aa) (STJ191668) | Login | Anti-CCNL2 antibody (400-480 aa) (STJ191668) | ||||||||||||||||
|
||||||||||||||||||
Anti-CCNT1 antibody (220-300 aa) (STJ191669) | Login | Anti-CCNT1 antibody (220-300 aa) (STJ191669) | ||||||||||||||||
|
||||||||||||||||||
Anti-CCNY antibody (270-350 aa) (STJ191671) | Login | Anti-CCNY antibody (270-350 aa) (STJ191671) | ||||||||||||||||
|
||||||||||||||||||
Anti-NDFIP2 antibody (STJ191926) | Login | Anti-NDFIP2 antibody (STJ191926) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDK19 antibody (30-110 aa) (STJ191675) | Login | Anti-CDK19 antibody (30-110 aa) (STJ191675) | ||||||||||||||||
|
||||||||||||||||||
Anti-CDK12 antibody (50-130 aa) (STJ191676) | Login | Anti-CDK12 antibody (50-130 aa) (STJ191676) | ||||||||||||||||
|
||||||||||||||||||
Anti-CD5L antibody (220-300 aa) (STJ191677) | Login | Anti-CD5L antibody (220-300 aa) (STJ191677) | ||||||||||||||||
|
||||||||||||||||||
Anti-SOX4 antibody (STJ191938) | Login | Anti-SOX4 antibody (STJ191938) | ||||||||||||||||
|
||||||||||||||||||
Anti-CYP2C9 antibody (STJ191939) | Login | Anti-CYP2C9 antibody (STJ191939) | ||||||||||||||||
|
||||||||||||||||||
Anti-PIK3C2A antibody (STJ191943) | Login | Anti-PIK3C2A antibody (STJ191943) | ||||||||||||||||
|
||||||||||||||||||
Anti-PIK3CB antibody (STJ191945) | Login | Anti-PIK3CB antibody (STJ191945) | ||||||||||||||||
|
||||||||||||||||||
Anti-PIK3R3 antibody (STJ191947) | Login | Anti-PIK3R3 antibody (STJ191947) | ||||||||||||||||
|
||||||||||||||||||
Anti-RIPK1 antibody (STJ191954) | Login | Anti-RIPK1 antibody (STJ191954) | ||||||||||||||||
|
||||||||||||||||||
Anti-MTIF2 antibody (450-530 aa) (STJ191551) | Login | Anti-MTIF2 antibody (450-530 aa) (STJ191551) | ||||||||||||||||
|
||||||||||||||||||
Anti-SART1 antibody (STJ191564) | Login | Anti-SART1 antibody (STJ191564) | ||||||||||||||||
|
||||||||||||||||||
Anti-LSM2 antibody (40-120 aa) (STJ191565) | Login | Anti-LSM2 antibody (40-120 aa) (STJ191565) | ||||||||||||||||
|
||||||||||||||||||
Anti-UBQLN2 antibody (STJ191566) | Login | Anti-UBQLN2 antibody (STJ191566) | ||||||||||||||||
|